NCT00739674
SAALT: Subtracting Salt and Adding Losartan Trial (0954A-335)
See it on ClinicalTrials.gov ↗863 people
51.8%
48.2%
447 womenmiddle line = equal numbers416 men
- Phase
- PHASE3
- Paid for by
- Organon and Co
- Finished
- 2010-01-01
- Health conditions
- Hypertension
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 55.38 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 89.6% · Asian 6.7% · Other 1.9% · Black / African American 1.5% · Hispanic / Latina 0.3%
Women left out
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Patient With Anuria Or Confirmed Clinically Significant Renal Or Hepatic Dysfunction (Taken From Current/Past Medical Records) And/Or Electrolyte Imbalance Laboratory Test Within The Last 3 Months Prior To Visit 1: Serum Creatinine \> 130 Ì…”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“…Aetiology (E.G., Uncorrected Renal Artery Stenosis, Malignant Hypertension, Hypertensive Encephalopathy. Patient With Symptomatic Heart Failure (Classes 3 And 4). Patient With A Prior Myocardial Infarction Or Stroke Within The Last 6 Months”
- No cancer
Women with current or past cancer were turned away.
“…condary Hypertension Of Any Aetiology (E.G., Uncorrected Renal Artery Stenosis, Malignant Hypertension, Hypertensive Encephalopathy. Patient With Symptomatic Heart Failure (Classes 3 And 4). Patient With A Prior Myocardial Infarction Or Str…”
Study titles and rules are shown in their original English.